| Patent Number |
Title Of Patent |
Date Issued |
| 6241991 |
Aviadenovirus |
June 5, 2001 |
| The invention relates to a new aviadenovirus which was isolated from a pigeon. The aviadenovirus according to the present invention comprises group-I specific antigen and cannot be neutralized by antiserum against any of the FAV serotypes 1-12. The present invention also relates to an |
| 6239183 |
Method for controlling the rheology of an aqueous fluid and gelling agent therefor |
May 29, 2001 |
| A method for controlling the rheology of aqueous systems, particularly for those intended for underground use, includes injecting an aqueous fluid containing a surfactant gelling agent into the system. The surfactant gelling agents are, for example, fatty aliphatic amidoamine oxides, sal |
| 6232451 |
Process for the preparation of organic azides |
May 15, 2001 |
| A process for the addition of an azide function to an organic compound in which process a mixture is prepared by adding an epoxide-derivative of the organic compound and an alkali metal azide salt to a solvent is described. The mixture is heated to a reaction temperature at which the |
| 6232093 |
Process for the production of heparin |
May 15, 2001 |
| The invention relates to a simplified process for the extraction of heparin from animal mucosa tissue. The method consists of an enzymatic hydrolysis step of the raw material at ambient temperature, followed by hydrolysis for up to 6 hours at a temperature of 50-75.degree. C. Raise in |
| 6228223 |
Composition for treatment of cellulosic material |
May 8, 2001 |
| The present invention generally relates to an aqueous softening and antistatic agent composition comprising a quaternary ammounium compound and a biodegradable nonionic surfactant, which composition comprises a quaternary ammounium compound having the formula ##STR1##wherein R.sub.1 |
| 6225361 |
Expanded hollow micro sphere composite beads and method for their production |
May 1, 2001 |
| The invention provides expanded hollow micro sphere composite beads and a process for producing the beads. According to the invention, finely divided calcium carbonate can be uniformly deposited on expanded hollow thermoplastic polymer micro spheres by a simple procedure without incu |
| 6225131 |
Device for performing an assay, a method for manufacturing said device, and use of a membrane in |
May 1, 2001 |
| A device for performing an assay comprising a substrate having through-going channels that open out onto a surface for sample application, the channels being provided in at least one cross-sectional area with a first binding substance capable of binding a particular analyte, the subs |
| 6222075 |
Process for the production of N, N, N', N',-tetra-(2-hydroxyethyl)ethylene diamine |
April 24, 2001 |
| A process is described for the production of N,N,N',N'-tetra-(2-hydroxyethyl)-ethylene diamine in a solvent, in which ethylene diamine is reacted selectively with ethylene oxide in the absence of water in one or more saturated C.sub.3 -C.sub.9 alcohols at a temperature from 120 to 22 |
| 6218448 |
Mixtures or pastes based on cellulose and the use thereof in coatings |
April 17, 2001 |
| The invention pertains to mixtures or pastes comprising a cellulose ester, a binder resin, water, and optionally a plasticiser, an organic solvent, an emulsifier, and/or a thickener, wherein in that at least a portion of the binder resin is functionalized with an amino-functional acetal. |
| 6218365 |
Serine protease inhibitors |
April 17, 2001 |
| The invention relates to a cornound having formula (I), wherein A, B, X, Y and r are as defined in the description, or a prodrug thereof or a pharnnaceutically acceptable salt thereof. The compounds of the invention have anticoagulant activity and can be used in treating or preventing |
| 6218154 |
Isothermal transcription based assay for the detection and quantification of chemokines rantes, |
April 17, 2001 |
| An isothermal transcription based amplification assay for the detection or quantification of chemokine RNA uses primers and probes for sequences within the gene for RANTES, MIP-1.alpha. and MIP-1 .beta.. The quantitative system uses an internal control Q of a mutant version of each g |
| 6214232 |
Membrane module with layered hollow-fiber membranes |
April 10, 2001 |
| An apparatus and process for substance-specific treatment of fluids, whereby the apparatus comprises a housing with a distribution space and a collection space, between which is arranged a structure of adjacent flat first and second layers containing first and second hollow-fiber mem |
| 6210651 |
Process for producing hydrogen peroxide |
April 3, 2001 |
| The invention relates to a process for continuously producing hydrogen peroxide comprising the steps of feeding hydrogen and oxygen containing gas to a reactor provided with a catalyst; contacting the hydrogen and oxygen gas with the catalyst and thereby forming hydrogen peroxide, and; |
| 6207599 |
Nonwoven backing and carpet comprising same |
March 27, 2001 |
| A nonwoven primary carpet backing includes thermoplastic polymer filaments or fibers bonded by means of a binder polymer. The backing includes at least a distinguishable thermoplastic woven layer, a distinguishable thermoplastic continuous layer, or a distinguishable nonwoven layer i |
| 6207128 |
Method of producing a catalyst |
March 27, 2001 |
| The invention relates to a method of producing a catalyst comprising a porous support and a catalytically active metal deposited thereon comprising the steps of treating the porous support with a solution of a salt of the catalytically active metal and a reducing agent to achieve ele |
| 6204024 |
CCR5 RNA transcription based amplification assay |
March 20, 2001 |
| A method and a test kit for genotyping the CCR5 chemokine receptor. CCR5 transcript DNA is amplified using transcription based amplification. The amplification product is detected through the hybridization of appropriately labeled oligonucleotide wild type and mutant probes. In a liq |
| 6203872 |
Waterproof and water vapour permeable lining |
March 20, 2001 |
| Proposed is a process for sealing the seams of a water vapour permeable lining comprising a laminate of a textile material and a waterproof, but water vapour permeable film in which sections of said laminate with the textile sides facing one another are bonded together along the contours |
| 6203801 |
Coccidiosis polypeptide and vaccines |
March 20, 2001 |
| The present invention relates to hydrophilic Eimeria polypeptides, DNA-fragments encoding those peptides, recombinant DNA molecules comprising such DNA-fragments, live recombinant carriers comprising such DNA-fragments or recombinant DNA molecules and host cells comprising such DNA-f |
| 6203607 |
Coating composition comprising polyacetoacetate, crosslinker and organosilane |
March 20, 2001 |
| The invention pertains to a coating composition comprising a polyacetoacetate, a crosslinker for said polyacetoacetate and an organosilane. The organosilane preferably comprises at least one amino group, amino containing-group, expoxy group, epoxy-containing group, mercapto group, me |
| 6200532 |
Devices and method for performing blood coagulation assays by piezoelectric sensing |
March 13, 2001 |
| A device and method for performing blood coagulation assays, particularly prothrombin times and activated partial thromboplastin times and other clotting parameters are disclosed. The device comprises a disposable strip (containing a sample inlet for sample delivery, a capillary channel |
| 6200464 |
FCC catalyst comprising coated zeolite particles |
March 13, 2001 |
| An FCC catalyst containing zeolite particles at least 50% of the outer surface of which is coated with a layer of pre-formed inorganic oxide is used in fluidized catalytic cracking of hydrocarbon feeds. The inorganic oxide layer has a thickness in the range of 10 nm to 5 .mu.m and the ra |
| 6197577 |
Sensor device for detecting microorganisms, and method therefor |
March 6, 2001 |
| A device and method allow for detecting the presence of microorganisms in clinical and non-clinical specimens. The device, a sensor, provides an environment to culture microbial organism colonies from a fluid sample, and a means to facilitate microbial detection and quantification, eithe |
| 6197291 |
Agent for potentiating the effect of interleukin-8 |
March 6, 2001 |
| The inventors provide an agent for potentiating the effect of interleukin-8, which comprises dehydroepiandrosterone sulfate or a pharmaceutically acceptable salt thereof as an active ingredient. An agent for potentiating the effect of IL-8 of the present invention potentiates the eff |
| 6194472 |
Petroleum hydrocarbon in water colloidal dispersion |
February 27, 2001 |
| A composition of a hydrocarbon in water colloidal dispersion including hydrocarbon particles having a mean softening point exceeding 95.degree. C., a water soluble dispersion agent and water, process and apparatus for the production thereof are disclosed. These dispersions have a median |
| 6194409 |
Heterocyclic derivatives and their use as antithrombotic agents |
February 27, 2001 |
| The present invention relates to antithrombotic compounds comprising the group Q, Q having formula (I), wherein the substructure (i) is a structure selected from (a, b and c), wherein X is O or S; X' being independently CH or N; and m is 0, 1, 2 or 3; wherein the group Q is bound through |
| 6194345 |
Process for activating halogenated catalysts, catalysts obtained by this process, and use of the |
February 27, 2001 |
| The invention relates to a process of activating a supported acid catalyst, and consists in the conversion of Lewis acid-type acid sites which are deposited on a solid substrate into activated acid sites in a non-oxydizing acid medium. The catalyst is exposed to a phase of activation |
| 6193971 |
Dictyocaulus viviparus antigen for diagnosing lungworm infestation and for vaccination |
February 27, 2001 |
| An immunogenic protein (DV 18) isolated from lungworm Dictyocaulus viviparus including variants and fragments thereof, are described. DNA encoding such protein, methods of isolating and preparing such protein, antibodies against such protein, immunoassays using such protein, a vaccin |
| 6193103 |
Pill dispenser |
February 27, 2001 |
| A pill dispenser for releasably holding a collection of pills. The dispenser having a base plate and a cover rotatably mounted relative to the base plate. The collection of pills are housed individually in compartments in the holding means and an aperture allows for selective release |
| 6190596 |
Process for producing cellulosic shaped objects |
February 20, 2001 |
| A process for producing cellulosic shaped objects includes extruding and coagulating a solution of chemical wood pulp in a tertiary amine oxide, and possibly a liquid that does not dissolve wood pulp and is miscible with the tertiary amine oxide, the solution capable of being shaped into |
| 6187830 |
Process for the preparation of foamed articles |
February 13, 2001 |
| The present invention relates to a process for the preparation of a foamed article having a foam density of less than 180 kg/m.sup.3 and an average cell diameter of less than 1.5 mm comprising the extrusion of a molten semi-crystalline thermoplastic resin composition in the presence of a |
| 6187759 |
Canine parvovirus DNA vaccination |
February 13, 2001 |
| This invention relates to the use of a DNA vaccine for the manufacture of a medicament for use in eliciting an immune response against parvovirus in a maternally derived antibody positive animals. The DNA vaccine comprises a plasmid vector and at least one isolated nucleotide sequence en |
| 6187567 |
Methods and reagents for in situ amplification |
February 13, 2001 |
| The present invention provides in situ amplification methods for the detection of a target nucleic acid molecule. The methods use a molecule termed "molecular tape" to retain the amplified target nucleic acid molecule within a cell upon amplification. The molecular tape, which may be |
| 6187339 |
Solid pharmaceutical composition comprising an excipient capable of binding water |
February 13, 2001 |
| The invention concerns a solid pharmaceutical composition comprising less than 7% by weight of an oil or oily substance, a low dosage active ingredient, and a water insoluble non-cross-linked polymeric excipient capable of binding water and having a mean particle size greater than 150 |
| 6184399 |
Process for preparing a fatty acyl isethionate salt |
February 6, 2001 |
| A process is provided for preparing a fatty acyl isethionate salt of the formula R.sup.1 C(O)OR.sup.2 SO.sub.3 M which comprises reacting at least one fatty acid of the formula R.sup.1 C(O)OH with at least one hydroxyalkanesulfonic acid salt of the formula HOR.sup.2 SO.sub.3 M in the |
| 6184204 |
Peptides suitable for use in antigen specific immunosuppressive therapy |
February 6, 2001 |
| This invention relates to peptides consisting of 16 to 55 amino acids, said peptides comprising at least one of the amino acid sequences LVCYYTSWS (SEQ ID NO:60), FLCTHIIYS (SEQ ID NO:61), IIYSFANIS (SEQ ID NO:62), LKTLLSVGG (SEQ ID NO:63), FIKSVPPFL (SEQ ID NO:64), FDGLDLAWL (SEQ ID |
| 6184057 |
Method of manufacturing a photovoltaic foil |
February 6, 2001 |
| The invention pertains to a method of manufacturing a photovoltaic foil supported by a carrier and comprising a plurality of photovoltaic layers which together have the ability of generating electric current from incident light, a back-electrode layer on one side adjacent and parallel |
| 6180234 |
Cellulose fibers and yarns with a reduced tendency to form fibrils |
January 30, 2001 |
| A process for manufacturing cellulose fibers or yarns with a reduced tendency to form fibrils includes treating fibers or yarns, which are washed after the filament forming process but not yet dried, with a cross-linking agent. The process includes treating the fibers or yarns with r |
| 6177420 |
20-aralkyl-5.alpha.-pregnane derivatives |
January 23, 2001 |
| ##STR1##The invention relates to 20-aralkyl-5.alpha.-pregnane derivative having general formula (I), or a pharmaceutically acceptable salt thereof, wherein R.sub.1 is (H,OR), (H,OSO.sub.3 H) or NOR; R is H, (C.sub.1-6)alkyl or (C.sub.1-6)acyl; each of R.sub.2 and R.sub.3 is independe |
| 6174863 |
Carbohydrate derivatives |
January 16, 2001 |
| The invention relates to a carbohydrate derivative having formula I ##STR1##wherein R.sup.1 is (1-4C)alkoxy; R.sup.2, R.sup.3 and R.sup.4 are independently (1-4C)alkoxy or OSO.sub.3.sup.-, the total number of sulfate groups is 4, 5, or 6; and the twisted lines represent bonds either abov |
| 6166232 |
Process for producing ester quats |
December 26, 2000 |
| A process is described for producing ester quats of the formula (I) ##STR1## where X.sup.- is an anion of an inorganic or organic acid, R.sub.a is a C.sub.1 to C.sub.4 alkyl group, R.sub.b and R.sub.c are each, independently of one another, a C.sub.1 to C.sub.3 alkylene group, and |
| 6165259 |
Aqueous dispersions of hydrophobic material |
December 26, 2000 |
| The invention relates to an aqueous dispersion containing a dispersant and a disperse phase containing a hydrophobic material, the dispersant comprising an anionic compound having a molecular weight less than 50,000 and being selected from the group consisting of carbon-containing co |
| 6162219 |
Electrode |
December 19, 2000 |
| The present invention is related to an electrode for destruction of biological tissue, suitably tumor tissue such as cancer. Prior art electrodes suffers from several disadvantages, such as e.g. a non-uniform current distribution, resulting in a oval and unpredictable destruction zon |
| 6159894 |
Catalyst for dehydrogenation of amino alcohols to amino carboxylic acids or of ethylene glycol ( |
December 12, 2000 |
| Catalyst for dehydrogenating amino alcohols to aminocarboxylic acids or ethylene glycol (derivatives) to oxycarboxylic acids, said catalyst containing zirconium, copper and possibly an additional metal, whereby the cited metals are precipitated as hydroxides, washed, dried, calcined, and |
| 6159696 |
Isolated human BMP-4 promoter region |
December 12, 2000 |
| The isolated human bone morphogenic protein-4 (BMP-4) promoter region, a vector comprising the isolated promoter region, and host cells comprising the isolated promoter region is described. A method for the identification of potential therapeutic agents for use in the prevention and/or t |
| 6159601 |
Process for the manufacture of cellulosic fibers; and cellulosic fibers |
December 12, 2000 |
| Cellulosic fibers made from a solution of cellulose in a tertiary amine oxide and optionally water and which have a low tendency to fibrillate are produced by coagulating the fibers in at least two stages. The residence time of the fibers in the first coagulation stage is adjusted so tha |
| 6159597 |
Centrifugal spinning process for spinnable solutions |
December 12, 2000 |
| The invention pertains to a process for spinning fibers or filaments from a spinnable solution using a centrifuge of which the wall has one or more spinning orifices, in which process the spinnable solution is jetted from the centrifuge into a coagulant inside a jacket. The inner radius |
| 6159472 |
Intradermal Avian immunization with inactivated vaccines |
December 12, 2000 |
| The present invention relates to methods for immunizing birds using small volumes of vaccine. According to the invention, effective immunization can be accomplished with small, relatively concentrated quantities of inactivated vaccine administered by intradermal means. |
| 6156343 |
Controlled release preparation |
December 5, 2000 |
| A controlled release preparation consisting of a tablet containing (a) a mixture of a drug and a water-soluble polymer, or a solid dispersion thereof, (b) polyvinylalcohol and (c) one or more salts selected from the group consisting of trisodium citrate, sodium sulfate and sodium chlorid |
| 6156253 |
Process for preparing cellulose fibers |
December 5, 2000 |
| A process for preparing fibers from an optically anisotropic solution containing either one of cellulose or cellulose derivatives by extruding the solution through a non-corroding spinneret and coagulating the resulting extrudates in a coagulant, the coagulant being a liquid which co |
| 6153400 |
Device and method for microbial antibiotic susceptibility testing |
November 28, 2000 |
| A method and apparatus for performing microbial antibiotic susceptibility testing include disposable, multi-chambered susceptibility plates and an automated plate handler and image acquisition and processing instrument. The susceptibility plates are inoculated with a microorganism (any |
